Jubilant Pharmova Limited has postponed its board meeting, originally scheduled for August 7, 2026, to August 10, 2026, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026; the trading window for the company’s securities remains closed from July 1, 2026, and will continue to be closed until August 12, 2026, for designated persons and their immediate relatives.